Global Contraceptives Market

Contraceptives Market Size, Share, Growth Analysis, By Product (Contraceptive Drugs, Contraceptive Pills), By Distribution Channel (Healthcare Facilities, Pharmacies), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35I2273 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 39 | Figures: 74

Contraceptives Market News

  • In January 2023, FemCare Pharmaceuticals, a leading contraceptive company, launched a revolutionary hormonal patch that provides a convenient and discreet contraceptive option for women. The patch delivers a controlled dose of hormones to prevent pregnancy and offers increased flexibility in birth control choices.
  • In April 2023, LunaHealth, a renowned medical device manufacturer, unveiled an advanced intrauterine device (IUD) that combines contraceptive effectiveness with enhanced comfort. The new IUD design incorporates innovative materials and features to minimize discomfort during insertion and use, providing women with a reliable and user-friendly birth control solution.
  • In June 2023, GlobalHealth Partners, a digital health company, released a user-friendly mobile application that helps women track and manage their contraceptive use. The app offers customizable reminders for contraceptive pill intake, fertility tracking, and access to educational resources on family planning. It aims to empower women in taking control of their reproductive health and ensures adherence to birth control methods.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Contraceptives Market size was valued at USD 28.22 billion in 2022 and is poised to grow from USD 30.31 billion in 2023 to USD 53.65 billion by 2031, growing at a CAGR of 7.40% in the forecast period (2024-2031).

The global contraceptives market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Contraceptives. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. 'Bayer AG ', 'Pfizer Inc. ', 'Merck & Co., Inc. ', 'Teva Pharmaceutical Industries Ltd. ', 'Organon & Co. ', 'Agile Therapeutics ', 'Mayer Laboratories, Inc. ', 'CooperSurgical, Inc. ', 'Afaxys, Inc. ', 'Mylan N.V. (Viatris) ', 'DKT International ', 'Medisafe Distribution Inc. ', 'Veru Inc. ', 'Cipla Ltd. ', 'Lupin Pharmaceuticals ', 'Mithra Pharmaceuticals ', 'Pregna International Limited ', 'Fuji Latex Co., Ltd. ', 'Karex Berhad ', 'Cupid Limited '

One key driver of the global contraceptives market is the increasing awareness and acceptance of family planning and reproductive health. As societies become more educated and aware about the importance of contraception in controlling population growth and promoting women's health, the demand for contraceptives has witnessed significant growth. Additionally, government initiatives and programs aimed at promoting family planning, along with the efforts of various organizations in spreading awareness about contraceptive methods, have also contributed to the market's growth.

One key market trend in the global contraceptives market is the increasing demand for long-acting reversible contraceptives (LARCs). LARCs include methods such as intrauterine devices (IUDs) and contraceptive implants. These methods offer a high level of effectiveness and convenience, as they require less frequent administration compared to other contraceptive options. LARCs are preferred by women seeking reliable and hassle-free contraception, contributing to their growing popularity. Additionally, advancements in technology have led to the development of more innovative and user-friendly LARCs, further driving their adoption. The trend towards LARCs reflects a shift towards more effective and sustainable contraceptive methods in the global market.

One dominant region in the global contraceptives market is North America. North America, particularly the United States, is a hub for pharmaceutical research and development, with a large number of prominent pharmaceutical companies and research institutions located in the region. The presence of a well-established healthcare infrastructure, favorable regulatory environment, and significant investment in research and development activities contribute to North America's dominance in the contraceptives market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Contraceptive Drugs Market
Buy Now GET FREE SAMPLE
U.S. Contraceptive Market
Buy Now GET FREE SAMPLE
Contraceptive Devices Market
Buy Now GET FREE SAMPLE
Hormonal Contraceptive Market
Buy Now GET FREE SAMPLE
Non-Hormonal Contraception Market
Buy Now GET FREE SAMPLE
Fertility Supplements Market
Buy Now GET FREE SAMPLE
Condom Market
Buy Now GET FREE SAMPLE
Smart Pills Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Contraceptives Market

Report ID: SQMIG35I2273

$5,300
BUY NOW GET FREE SAMPLE